197 related articles for article (PubMed ID: 9523817)
1. Influence of acidosis on cardiotonic effects of milrinone.
Tanaka M; Ishikawa T; Nishikawa T; Goto K; Sato S
Anesthesiology; 1998 Mar; 88(3):725-34. PubMed ID: 9523817
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of the bipyridines: amrinone and milrinone.
Alousi AA; Johnson DC
Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
[TBL] [Abstract][Full Text] [Related]
3. Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria.
Muller B; Lugnier C; Stoclet JC
J Cardiovasc Pharmacol; 1990 Mar; 15(3):444-51. PubMed ID: 1691369
[TBL] [Abstract][Full Text] [Related]
4. The effect of reduced myocardial cyclic AMP content on the response to milrinone in the isolated guinea pig heart.
Kehler CH; Hebl JR; Soule CL; Gallagher WJ; Houlton AJ
J Heart Lung Transplant; 1997 Jun; 16(6):636-42. PubMed ID: 9229294
[TBL] [Abstract][Full Text] [Related]
5. [Milrinone decreases the positive inotropic response of heart muscle to izadrin].
Bardamova IB; Afanas'ev SA
Eksp Klin Farmakol; 1994; 57(4):29-31. PubMed ID: 7950778
[TBL] [Abstract][Full Text] [Related]
6. Myocardial actions of milrinone: characterization of its mechanism of action.
Rapundalo ST; Grupp I; Grupp G; Abdul Matlib M; Solaro RJ; Schwartz A
Circulation; 1986 Mar; 73(3 Pt 2):III134-44. PubMed ID: 2417746
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone.
Fujino K; Sperelakis N; Solaro RJ
Circ Res; 1988 Nov; 63(5):911-22. PubMed ID: 2846200
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle.
Silver PJ; Harris AL; Canniff PC; Lepore RE; Bentley RG; Hamel LT; Evans DB
J Cardiovasc Pharmacol; 1989 Apr; 13(4):530-40. PubMed ID: 2470989
[TBL] [Abstract][Full Text] [Related]
9. The role of cyclic AMP and the dihydropyridine-sensitive channels on the mechanism of action of milrinone (Corotrope).
Frangakis CJ; Lanni C; Lasher KP; Bentley RG; Farah AE
J Cardiovasc Pharmacol; 1989 Jun; 13(6):915-24. PubMed ID: 2484087
[TBL] [Abstract][Full Text] [Related]
10. An analysis of the mechanism of the inotropic action of some milrinone analogues in guinea-pig isolated atria.
Dorigo P; Gaion RM; Belluco P; Mosti L; Borea PA; Maragno I
Br J Pharmacol; 1991 Dec; 104(4):867-72. PubMed ID: 1810600
[TBL] [Abstract][Full Text] [Related]
11. Cardiotonic activity of 5-methyl-6-(4-pyridyl)-2H-1,4-thiazin-3(4H)-one hydrochloride (ZSY-27).
Yoshioka K; Hino M; Yoshimura A; Yamazaki H; Takase M; Ono H
J Pharmacobiodyn; 1988 Nov; 11(11):715-21. PubMed ID: 3236203
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan.
Abe Y; Kitada Y; Narimatsu A
J Pharmacol Exp Ther; 1992 Jun; 261(3):1087-95. PubMed ID: 1602375
[TBL] [Abstract][Full Text] [Related]
13. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
Endoh M; Yanagisawa T; Taira N; Blinks JR
Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745
[TBL] [Abstract][Full Text] [Related]
14. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
Haikala H; Kaheinen P; Levijoki J; Lindén IB
Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
[TBL] [Abstract][Full Text] [Related]
15. Calcium sensitization in perfused beating guinea pig heart by a positive inotropic agent MCI-154.
Abe Y; Ishisu R; Onishi K; Sekioka K; Narimatsu A; Nakano T
J Pharmacol Exp Ther; 1996 Feb; 276(2):433-9. PubMed ID: 8632307
[TBL] [Abstract][Full Text] [Related]
16. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
Ahn HS; Eardley D; Watkins R; Prioli N
Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular pharmacology of the vasodilator-cardiotonic agent, 349U85.
Steffen RP; Wastila WB
J Cardiovasc Pharmacol; 1992 Oct; 20(4):579-89. PubMed ID: 1280714
[TBL] [Abstract][Full Text] [Related]
18. Cardiac and hemodynamic profile of the new cardiotonic agent, DPI 201-106, in the conscious dog.
Gerard JL; Berdeaux A; Giudicelli JF
Eur J Pharmacol; 1989 Jun; 165(1):39-49. PubMed ID: 2767134
[TBL] [Abstract][Full Text] [Related]
19. Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle.
Satoh H; Endoh M
Jpn J Pharmacol; 1990 Feb; 52(2):215-24. PubMed ID: 2156096
[TBL] [Abstract][Full Text] [Related]
20. In-vivo effects of amrinone and milrinone on left ventricular dP/dt, intraventricular pressure and heart rate in pentobarbital-anesthetized guinea pigs.
Lin BB; Chen HL
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):237-40. PubMed ID: 1811284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
